States Win 1st OK Of $400M Sandoz Generic Price-Fixing Deal
By Brian Steele · October 16, 2026, 5:37 PM EDT
A Connecticut federal judge granted preliminary approval Friday to a $400 million settlement between a coalition of states, Sandoz Inc. and its subsidiary Fougera Pharmaceuticals Inc. over allegations of generic drug...
To view the full article, register now.